Effect of Proton Pump Inhibitor Based Triple Therapy with Apple Cider Vinegar on Helicobacter Pylori Eradication

Shaahin Shahbazi, Zahra Vahdat Shariatpanahi, Nourkhoda Sadeghifard

Background: The purpose of this study was to evaluate the effect of apple cider vinegar plus PPI-based triple therapy on eradication of Helicobacter Pylori (H.pylori) infection.

Materials and Methods: 116 patients with H. pylori infection were included in this randomized clinical trial. Patients in control group (n=59) received amoxicillin, clarithromycin, and pantaprazole twice daily. Patients in study group (57 patients) received the same regimen plus 30 mL of apple cider vinegar twice daily. The duration of therapy for study and control were 10 and 14 days respectively. Four weeks after the completion of therapy, Urea breath test was performed to assess the success of H.pylori infection eradication.

Results: 86% of patients in control group in comparison to 88% in apple cider vinegar group responded to eradication therapy (P=0.41).

Conclusion: Addition of apple cider vinegar to proton pomp inhibitor (PPI)-based triple therapy may decrease the duration of H. pylori treatment but it was not statistically significant. Thus, our results showed no efficacy of apple cider vinegar in H. pylory eradication treatment.

Apple cider vinager; Helicobacter pylori; endoscopy; proton pump inhibitor; antibacterial treatment

Kusters JG, van Vliet AH, Kuipers EJ. Pathogenesis of Helicobacter pylori infection. Clin Microbiol Rev. 2006;19(3):449-90.

Qasim A, Sebastian S, Thornton O, Dobson M, McLoughlin R, Buckley M, et al. Rifabutin‐and furazolidone‐based Helicobacter pylori eradication therapies after failure of standard first‐and second‐line eradication attempts in dyspepsia patients. Aliment Pharmacol Ther. 2005;21(1):91-6.

Gatta L, Zullo A, PERNA F, Ricci C, De Francesco V, Tampieri A, et al. A 10‐day levofloxacin‐based triple therapy in patients who have failed two eradication courses. Aliment Pharmacol Ther. 2005;22(1):45-9.

Gisbert JP, Gonzalez L, Calvet X. Systematic Review and Meta‐analysis: Proton Pump Inhibitor vs. Ranitidine Bismuth Citrate Plus Two Antibiotics in Helicobacter pylori Eradication. Helicobacter. 2005;10(3):157-71.

Fischbach L, Zanten S, Dickason J. Meta‐analysis: the efficacy, adverse events, and adherence related to first‐line anti‐Helicobacter pylori quadruple therapies. Aliment Pharmacol Ther. 2004;20(10):1071-82.

Graham D, Hammoud F, El‐Zimaity H, Kim J, Osato M, El‐Serag H. Meta‐analysis: proton pump inhibitor or H2‐receptor antagonist for Helicobacter pylori eradication. Aliment Pharmacol Ther s. 2003;17(10):1229-36.

Vakil N. Primary and secondary treatment for Helicobacter pylori in the United States. Rev Gastroenterol Disord. 2005;5(2):67-72.

Wittschier N, Faller G, Hensel A. Aqueous extracts and polysaccharides from Liquorice roots (Glycyrrhiza glabra L.) inhibit adhesion of Helicobacter pylori to human gastric mucosa. J Ethnopharmacol. 2009;125(2):218-23.

Ki M-R, Ghim S-Y, Hong I-H, Park J-K, Hong K-S, Ji A-R, et al. In vitro inhibition of Helicobacter pylori growth and of adherence of cagA-positive strains to gastric epithelial cells by Lactobacillus paraplantarum KNUC25 isolated from kimchi. J Med Food. 2010;13(3):629-34.

Bekar O, Yilmaz Y, Gulten M. Kefir improves the efficacy and tolerability of triple therapy in eradicating Helicobacter pylori. J Med Food. 2011;14(4):344-7.

Molnár P, Deli J, Tanaka T, Kann Y, Tani S, Gyémánt N, et al. Carotenoids with anti‐Helicobacter pylori activity from Golden delicious apple. Phytother Res. 2010;24(5):644-8.

Dornelles-Morgental R, Guerreiro-Tanomaru JM, de Faria-Júnior NB, Hungaro-Duarte MA, Kuga MC, Tanomaru-Filho M. Antibacterial efficacy of endodontic irrigating solutions and their combinations in root canals contaminated with Enterococcus faecalis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2011;112(3):396-400.

Lu HJ, Breidt J, Perez-Diaz IM, Osborne JA. Antimicrobial effects of weak acids on the survival of Escherichia coli O157: H7 under anaerobic conditions. J Food Prot. 2011;74(6):893-8.

Podbeltsev D, Nikitiuk D, Pozdniakov A. Influence of prebiotics on morphologic structure of the mucouse membrane of intestinum crassum of rats. Vopr Pitan. 2006;75(2):26-9.

Osato MS, Reddy R, Reddy SG, Penland RL, Malaty HM, Graham DY. Pattern of primary resistance of Helicobacter pylori to metronidazole or clarithromycin in the United States. Arch Intern Med. 2001;161(9):1217-20.

de Boer WA, Tytgat GN. The best therapy for Helicobacter pylori infection: should efficacy or side-effect profile determine our choice? Scand J Gastroenterol. 1995;30(5):401-7.

Vakil N. Helicobacter pylori: factors affecting eradication and recurrence. Am J Gastroenterol. 2005;100(11):2393-4.

Cindoruk M, Erkan G, Karakan T, Dursun A, Unal S. Efficacy and Safety of Saccharomyces boulardii in the 14‐day Triple Anti‐Helicobacter pylori Therapy: A Prospective Randomized Placebo‐Controlled Double‐Blind Study. Helicobacter. 2007;12(4):309-16.

Song MJ, Park DI, Park JH, Kim HJ, Cho YK, Sohn CI, et al. The Effect of Probiotics and Mucoprotective Agents on PPI‐Based Triple Therapy for Eradication of Helicobacter pylori. Helicobacter. 2010;15(3):206-13.

Lesbros-Pantoflickova D, Corthesy-Theulaz I, Blum AL. Helicobacter pylori and probiotics. J Nutr. 2007;137(3 Suppl 2):812S-8S.

Kaur IP, Kuhad A, Garg A, Chopra K. Probiotics: delineation of prophylactic and therapeutic benefits. J Med Food. 2009;12(2):219-35.

Franceschi F, Cazzato A, Nista EC, Scarpellini E, Roccarina D, Gigante G, et al. Role of probiotics in patients with Helicobacter pylori infection. Helicobacter. 2007;12 Suppl 2:59-63.

Wakuda T, Azuma K, Saimoto H, Ifuku S, Morimoto M, Arifuku I, et al. Protective effects of galacturonic acid-rich vinegar brewed from Japanese pear in a dextran sodium sulfate-induced acute colitis model. J Funct Foods. 2012.

Budak NH, Kumbul Doguc D, Savas CM, Seydim AC, Kok Tas T, Ciris MI, et al. Effects of apple cider vinegars produced with different techniques on blood lipids in high-cholesterol-fed rats. J Agric Food Chem. 2011;59(12):6638-44.

Correa P, Fontham ET, Bravo JC, Bravo LE, Ruiz B, Zarama G, et al. Chemoprevention of gastric dysplasia: randomized trial of antioxidant supplements and anti-Helicobacter pylori therapy. J Natl Cancer Inst. 2000;92(23):1881-8.

Kohler JE, Blass AL, Liu J, Tai K, Soybel DI. Antioxidant pre-treatment prevents omeprazole-induced toxicity in an in vitro model of infectious gastritis. Free Radic Biol Med. 2010;49(5):786-91.

Budak HN, Guzel‐Seydim ZB. Antioxidant activity and phenolic content of wine vinegars produced by two different techniques. J Sci Food Agric. 2010;90(12):2021-6.


  • There are currently no refbacks.